Stock 1061 ESSEX BIO-TECHNOLOGY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Essex Bio-Technology Limited

Equities

1061

KYG312371035

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:13 2024-04-23 am EDT 		5-day change 1st Jan Change
2.25 HKD -3.02% Intraday chart for Essex Bio-Technology Limited 0.00% -9.64%
Mar. 18 Essex Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 03 Essex Bio-Technology Limited Announces Change of Address of Head Office And principal Place of Business in Hong Kong CI

Business Summary

Essex Bio-Technology Ltd is an investment holding company principally engaged in the manufacture and sales of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Company develops biopharmaceutical drugs based on recombinant deoxyribonucleic acid (DNA) technology. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin. The Company operates through two segments. The Surgical segment is engaged in the manufacture and sale of Beifuji spray, Beifuji lyophilised powder and Beifuxin gel. The Ophthalmology segment is engaged in the manufacture and sale of Beifushu eye drops, Beifushu eye gel and Beifushu unit-dose eye drops.

Number of employees: 1,481

Sales per Business

HKD in Million2022Weight2023Weight Delta
Surgical
55.9 %
764 58.0 % 953 55.9 % +24.73%
Ophthalmology
44.1 %
554 42.0 % 753 44.1 % +36.10%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
1,318 100.0 % 1,707 100.0 % +29.51%

Managers

Managers TitleAgeSince
Hai Zhou Fang CEO
 Chief Executive Officer 58 00-07-30
Qi Xue CTO
 Chief Tech/Sci/R&D Officer 63 18-04-08
Hian Leng Ngiam BRD
 Director/Board Member 40 14-12-31
Lai Man Yau BRD
 Director/Board Member 60 00-12-31

Members of the board

Members of the board TitleAgeSince
Mia Je Ngiam FOU
 Founder 70 99-01-31
Lai Man Yau BRD
 Director/Board Member 60 00-12-31
Mee Mooi Yeow BRD
 Director/Board Member 72 04-09-29
Hai Zhou Fang CEO
 Chief Executive Officer 58 00-07-30
Chi Ying Fung BRD
 Director/Board Member 69 01-06-12
Hian Leng Ngiam BRD
 Director/Board Member 40 14-12-31
Man Sing Yan BRD
 Director/Board Member 66 23-06-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 567,540,000 260,911,033 ( 45.97 %) 0 45.97 %

Shareholders

NameEquities%Valuation
Mia Je Ngiam
27.13 %
153,945,667 27.13 % 46 M $
Essex Investment (Singapore) Pte Ltd.
1.175 %
6,666,667 1.175 % 2 M $
Hai Zhou Fang
0.9240 %
5,244,300 0.9240 % 2 M $
Pheim Asset Management Sdn. Bhd.
0.6454 %
3,662,700 0.6454 % 1 M $
Hian Leng Ngiam
0.3593 %
2,039,000 0.3593 % 612 230 $
Lacuna Vermögen GmbH
0.2546 %
1,445,000 0.2546 % 433 876 $
CATAM Asset Management AG
0.0529 %
299,999 0.0529 % 90 078 $
Dimensional Fund Advisors Ltd.
0.0323 %
183,151 0.0323 % 54 993 $
DFA Australia Ltd.
0.0136 %
76,952 0.0136 % 23 106 $
AXA Investment Managers Asia (Singapore) Ltd.
0.0120 %
68,000 0.0120 % 20 418 $

Company contact information

Essex Bio-Technology Ltd.

West Tower, Shun Tak Centre 168-200 Connaught Road

, Hong Kong

+

http://www.essexbio.com
address Essex Bio-Technology Limited(1061)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
ESSEX BIO-TECHNOLOGY LIMITED Stock Essex Bio-Technology Limited
-9.64% 168M
CSL LIMITED Stock CSL Limited
-2.68% 85.68B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+4.08% 41.4B
BIOGEN INC. Stock Biogen Inc.
-25.35% 28.22B
UCB Stock UCB
+54.31% 24.64B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-4.52% 16.98B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.09% 13.29B
INCYTE CORPORATION Stock Incyte Corporation
-17.77% 11.66B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.10% 11.65B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+0.75% 8.18B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 1061 Stock
  4. Company Essex Bio-Technology Limited